Takeda Loses Patent Fight Over Roche's Hemlibra Drug
A federal court in Delaware has said that a Takeda Pharmaceutical Co. Ltd. unit's patent covering antibodies isn't valid after all, sinking the Japanese multinational's infringement case against the Roche-owned company...To view the full article, register now.
Already a subscriber? Click here to view full article